美邦股份在印度尼西亚成功获批五个原药登记证

Core Viewpoint - Meibang Co., Ltd. has made significant progress in the Indonesian market by obtaining five drug registration certificates, enhancing its presence in Southeast Asia [1] Group 1 - Meibang Co., Ltd. has received approval for five original drug registration certificates in Indonesia [1] - The company is actively registering multiple products in Indonesia, with expectations for more approvals in the next two years [1]